Ravn virus

Source: Wikipedia, the free encyclopedia.
Ravn virus
Virus classification Edit this classification
(unranked): Virus
Realm: Riboviria
Kingdom: Orthornavirae
Phylum:
Negarnaviricota
Class: Monjiviricetes
Order: Mononegavirales
Family: Filoviridae
Genus: Marburgvirus
Species:
Marburg marburgvirus
Virus:
Ravn virus

Ravn virus (/ˈrævən/;[1] RAVV) is a close relative of Marburg virus (MARV). RAVV causes Marburg virus disease in humans and nonhuman primates, a form of viral hemorrhagic fever.[2] RAVV is a Select agent,[3] World Health Organization Risk Group 4 Pathogen (requiring Biosafety Level 4-equivalent containment),[4] National Institutes of Health/National Institute of Allergy and Infectious Diseases Category A Priority Pathogen,[5] Centers for Disease Control and Prevention Category A Bioterrorism Agent,[6] and listed as a Biological Agent for Export Control by the Australia Group.[7]

Use of term

Ravn virus (today abbreviated RAVV, but then considered identical to Marburg virus) was first described in 1987 and is named after a 15-year old Danish boy who fell ill and died from it.

Marburg marburgvirus, which is included into the genus Marburgvirus, family Filoviridae, order Mononegavirales. The name Ravn virus is derived from Ravn (the name of the Danish patient from whom this virus was first isolated) and the taxonomic suffix virus.[1]

Previous designations

Ravn virus was first introduced as a new subtype of Marburg virus in 1996.[8] In 2006, a whole-genome analysis of all marburgviruses revealed the existence of five distinct genetic lineages. The genomes of representative isolates of four of those lineages differed from each other by only 0-7.8% on the nucleotide level, whereas representatives of the fifth lineage, including the new "subtype", differed from those of the other lineages by up to 21.3%.[9] Consequently, the fifth genetic lineage was reclassified as a virus, Ravn virus (RAVV), distinct from the virus represented by the four more closely related lineages, Marburg virus (MARV).[1]

Virus inclusion criteria

A virus that fulfills the criteria for being a member of the species

Marburg marburgvirus is a Ravn virus if it has the properties of Marburg marburgviruses and if its genome diverges from that of the prototype Marburg marburgvirus, Marburg virus variant Musoke (MARV/Mus), by ≥10% but from that of the prototype Ravn virus (variant Ravn) by <10% at the nucleotide level.[1]

Disease

RAVV is one of two marburgviruses that causes Marburg virus disease (MVD) in humans (in the literature also often referred to as Marburg hemorrhagic fever, MHF). MVD due to RAVV infection cannot be differentiated from MVD caused by MARV by clinical observation alone, which is why the clinical presentation and pathology of infections by all marburgviruses is presented together on a separate page (see Marburg virus disease (MVD)). [citation needed]In the past, RAVV has caused the following MVD outbreaks:

Marburg virus disease (MVD) outbreaks due to Ravn virus (RAVV) infection
Year Geographic location Human cases/deaths (case-fatality rate)
1987 Kenya 1/1 (100%)[8]
1998–2000 ? (A total of 154 cases and 128 deaths of marburgvirus infection were recorded during this outbreak. The case fatality was 83%. Two different marburgviruses, RAVV and Marburg virus (MARV), cocirculated and caused disease. It has never been published how many cases and deaths were due to RAVV or MARV infection)[10][11][12]
2007 Uganda 0/1 (0%)[13][14]

Ecology

In 2009, the successful isolation of infectious RAVV was reported from caught healthy Egyptian rousettes (Rousettus aegyptiacus).[13] This isolation, together with the isolation of infectious MARV, strongly suggests that Old World fruit bats are involved in the natural maintenance of marburgviruses.[13]

References

  1. ^
    PMID 21046175
    .
  2. ^ Spickler, Anna. "Ebolavirus and Marburgvirus Infections" (PDF).
  3. ^ US Animal and Plant Health Inspection Service (APHIS) and US Centers for Disease Control and Prevention (CDC). "National Select Agent Registry (NSAR)". Retrieved 2011-10-16.
  4. ^ US Department of Health and Human Services. "Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition". Retrieved 2011-10-16.
  5. ^ US National Institutes of Health (NIH), US National Institute of Allergy and Infectious Diseases (NIAID). "Biodefense - NIAID Category A, B, and C Priority Pathogens". Retrieved 2011-10-16.
  6. ^ US Centers for Disease Control and Prevention (CDC). "Bioterrorism Agents/Diseases". Archived from the original on 2014-07-22. Retrieved 2011-10-16.
  7. ^ The Australia Group. "List of Biological Agents for Export Control". Archived from the original on 2011-08-06. Retrieved 2011-10-16.
  8. ^
    PMID 8800792. {{cite book}}: |journal= ignored (help
    )
  9. .
  10. .
  11. .
  12. PMID 16943403. Archived from the original
    (PDF) on 2022-12-29. Retrieved 2018-12-31.
  13. ^ .
  14. .

Further reading

External links